Single-cell and spatial protein transcriptomics have identified RE1 silencing factor (REST) as a potential biomarker for small cell lung cancer, associated with low neuroendocrine features, increased anti-tumor immunity, and prolonged survival [235]. This evidence concerns the gene REST and neoplasm.